Rekah Pharmaceutical (Israel) Price on December 11, 2024
| REKA Stock | ILA 1,400 8.00 0.57% |
If you're considering investing in Rekah Stock, it is important to understand the factors that can impact its price. As of today, the current price of Rekah Pharmaceutical stands at 1,400, as last reported on the 14th of December 2024, with the highest price reaching 1,400 and the lowest price hitting 1,388 during the day. At this point, Rekah Pharmaceutical is very steady. Rekah Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of 0.0183, which implies the firm had a 0.0183% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Rekah Pharmaceutical, which you can use to evaluate the volatility of the company. Please check Rekah Pharmaceutical's Semi Deviation of 3.51, coefficient of variation of 3907.68, and Risk Adjusted Performance of 0.0265 to confirm if the risk estimate we provide is consistent with the expected return of 0.0681%.
Rekah Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Rekah |
Sharpe Ratio = 0.0183
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | REKA | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.71 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Rekah Pharmaceutical is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rekah Pharmaceutical by adding it to a well-diversified portfolio.
Rekah Pharmaceutical Valuation on December 11, 2024
It is possible to determine the worth of Rekah Pharmaceutical on a given historical date. On December 11, 2024 Rekah was worth 1382.0 at the beginning of the trading date compared to the closed value of 1400.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Rekah Pharmaceutical stock. Still, in general, we apply an absolute valuation method to find Rekah Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rekah Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Rekah Pharmaceutical's related companies.
| Open | High | Low | Close | Volume | |
| 1,392 | 1,392 | 1,382 | 1,392 | 28.00 | |
12/11/2024 | 1,382 | 1,410 | 1,354 | 1,400 | 2,585 |
| 1,400 | 1,400 | 1,388 | 1,400 | 13.00 |
| Backtest Rekah Pharmaceutical | | | Rekah Pharmaceutical History | | | Rekah Pharmaceutical Valuation | Previous | Next |
Rekah Pharmaceutical Trading Date Momentum on December 11, 2024
| On December 12 2024 Rekah Pharmaceutical Industry was traded for 1,400 at the closing time. The highest price during the trading period was 1,400 and the lowest recorded bid was listed for 1,388 . The volume for the day was 13.0. This history from December 12, 2024 did not cause price change. The trading delta at closing time to the current price is 0.00% . |
Rekah Pharmaceutical Fundamentals Correlations and Trends
By evaluating Rekah Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Rekah Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Rekah financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Rekah Pharmaceutical Stock history
Rekah Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rekah is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rekah Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rekah Pharmaceutical stock prices may prove useful in developing a viable investing in Rekah Pharmaceutical
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company was founded in 1941 and is based in Holon, Israel. REKAH PHARMA operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 9 people.
Rekah Pharmaceutical Stock Technical Analysis
Rekah Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Rekah Pharmaceutical Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Rekah Pharmaceutical Industry cannot be verified against its exchange. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Rekah Pharmaceutical December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Rekah Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rekah Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Rekah Pharmaceutical stock market strength indicators, traders can identify Rekah Pharmaceutical Industry entry and exit signals to maximize returns
Rekah Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rekah Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Rekah Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rekah to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0265 | |||
| Jensen Alpha | 0.1296 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0.15) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Rekah Stock analysis
When running Rekah Pharmaceutical's price analysis, check to measure Rekah Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rekah Pharmaceutical is operating at the current time. Most of Rekah Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Rekah Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rekah Pharmaceutical's price. Additionally, you may evaluate how the addition of Rekah Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |